Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen‐deprivation therapy for hormone‐naïve bone‐metastatic prostate cancer.
Leading the teacher team — balancing between formal and informal power in program leadership.
Tertiary Education and Management.
A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial.
Annals of Oncology.
Clinical characteristics and quality‐of‐life in patients surviving a decade of prostate cancer with bone metastases.